MicroRNA-200 is commonly repressed in conjunctival MALT lymphoma, and targets cyclin E2

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 250, Issue 4, 2012, Pages 523-531

  Cai, Jiping ^a   Liu, Xiaoyu ^b   Cheng, Jinwei ^a   Li, You ^a   Huang, Xiao ^a   Li, Yuzhen ^a   Ma, Xiaoye ^a   Yu, Hongyu ^a   Liu, Huimin ^a   Wei, Ruili ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cyclin E2; MALT lymphoma; MicroRNA; miR 200; Ocular adnexa

Indexed keywords

CYCLIN E; CYCLIN E2; MICRORNA 150; MICRORNA 155; MICRORNA 184; MICRORNA 200; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 205; UNCLASSIFIED DRUG; CCNE2 PROTEIN, HUMAN; CYCLINE; MICRORNA; MIRN200 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVAL MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; GENE REPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MALE; MICROARRAY ANALYSIS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; CELL STRAIN HEK293; CONJUNCTIVA TUMOR; DNA MICROARRAY; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; MARGINAL ZONE LYMPHOMA; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CONJUNCTIVAL NEOPLASMS; CYCLINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84861324713     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1885-4     Document Type: Article

References (44)

1. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
2. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA (2003) Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 229:838-846
3. Garzon R, Calin GA, Croce CM (2009) MicroRNAs in cancer. Annu Rev Med 60:167-179
4. Negrini M, Nicoloso MS, Calin GA (2009) MicroRNAs and cancer-new paradigms in molecular oncology. Curr Opin Cell Biol 21:470-479
5. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM (2005) A microRNA polycistron as a potential human oncogene. Nature 435:828-833
6. Hardman-Lea S, Kerr-Muir M, Wotherspoon AC, Green WT, Morell A, Isaacson PG (1994) Mucosa-associated lymphoid tissue lymphoma of the conjunctiva. Arch Ophthalmol 112:1207-1212
7. Coupland SE, Krause L, Delecluse HJ, Anagnostopoule I, Foss HD, Hummel M, Bornfeld N, Lee WR, Stein H (1998) Lymphoproliferative lesions of the ocular adnexa: analysis of 112 cases. Ophthalmology 105:1430-1441
8. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E, Dahlberg JE (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 102:3627-3632
9. Hans CP,Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275-282
10. Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, Paterson JC, Cattan H, Enver T, Mager R, Boultwood J, Wainscoat JS, Hatton CS (2007) MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 121:1156-1161
11. Lum AM, Wang BB, Li L, Channa N, Bartha G, Wabl M (2007) Retroviral activation of the mir-106a microRNA cistron in Tlymphoma. Retrovirology 4:5
12. Rinaldi A, Poretti G, Kwee I, Zucca E, Catapano CV, Tibiletti MG, Bertoni F (2007) Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma. Leuk Lymphoma 48:410-412
13. Wang CL, Wang BB, Bartha G, Li L, Channa N, Klinger M, Killeen N, Wabl M (2006) Activation of an oncogenic microRNA cistron by provirus integration. Proc Natl Acad Sci U S A 103:18680-18684
14. Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, Kroesen BJ, vanden Berg A (2005) BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207:243-249
15. Dykxhoorn DM (2010) MicroRNAs and metastasis: little RNAs go a long way. Cancer Res 70:6401-6406
16. Korpal M, Kang Y (2008) The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol 5:115-119
17. Park SM, Gaur AB, Lengyel E, Peter ME (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22:894-907
18. Cochrane DR, Howe EN, Spoelstra NS, Richer JK (2010) Loss of miR-200c: a marker of aggressiveness and chemoresistance in female reproductive cancers. J Oncol 2010:821717
19. Shinozaki A, Sakatani T, Ushiku T, Hino R, Isogai M, Ishikawa S, Uozaki H, Takada K, Fukayama M (2010) Downregulation of microRNA-200 in EBV-associated gastric carcinoma. Cancer Res 70:4719-4727
20. Yu J, Ohuchida K, Mizumoto K, Sato N, Kayashima T, Fujita H, Nakata K, Tanaka M (2010) MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol Cancer 9:169
21. Jaffe ES (2009) The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program:523-531
22. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-D158
23. Gao X, Gulari E, Zhou X (2004) In situ synthesis of oligonucleotide microarrays. Biopolymers 73:579-596
24. Zhu Q, Hong A, Sheng N, Zhang X, Matejko A, Jun KY, Srivannavit O, Gulari E, Gao X, Zhou X (2007) microParaflo biochip for nucleic acid and protein analysis. Methods Mol Biol 382:287-312
25. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatinmodifying drugs in human cancer cells. Cancer Cell 9:435-443
26. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ (2005) Real-time quantification of micro-RNAs by stem-loop RT-PCR. Nucleic Acids Res 33:e179
27. Stommel JM, Wahl GM (2004) Accelerated MDM2 autodegradation induced by DNA-damage kinases is required for p53 activation. EMBO J 23:1547-1556
28. Cui B, Johnson SP, Bullock N, Ali-Osman F, Bigner DD, Friedman HS (2009) Bifunctional DNA alkylator 1,3-bis(2-chloroethyl)-1-nitrosourea activates the ATR-Chk1 pathway independently of the mismatch repair pathway. Mol Pharmacol 75:1356-1363
29. Coupland SE, White VA, Rootman J, Damato B, Finger PT (2009) ATNM-based staging system for ocular adnexal lymphomas. Arch Path Lab Med 133:1262-1267
30. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:1860-1861
31. Peter ME (2009) Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8:843-852
32. Moroy T, Geisen C (2004) Cyclin E. Int J Biochem Cell Biol 36:1424-1439
33. Sjö LD, Ralfkiaer E, Prause JU, Petersen JH, Madsen J, Pedersen NT, Heegaard S (2008) Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005. Invest Ophthalmol Vis Sci 49:3283-3288
34. Decaudin D, de Cremoux P, Vincent-Salomon A, Dendale R, Rouic LL (2006) Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood 108:1451-1460
35. Shields CL, Shields JA (2004) Tumors of the conjunctiva and cornea. Surv Ophthalmol 49:3-24
36. Shields CL, Shields JA, Carvalho C, Rundle P, Smith AF (2001) Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma. Ophthalmology 108:979-984
37. Zullo A, Hassan C, Cristofari F, Perri F, Morini S (2010) Gastric low-grade mucosal-associated lymphoid tissue-lymphoma: Helicobacter pylori and beyond. World J Gastrointest Oncol 2:181-186
38. Stolte M (1992) Helicobacter pylore gastritis and gastric MALTlymphoma. Lancet 339:745-746
39. Bertoni F, Zucca E (2005) State-of-the-art therapeutics: marginalzone lymphoma. J Clin Oncol 23:6415-6420
40. Culpin RE, Proctor SJ, Angus B, Crosier S, Anderson JJ, Mainou-Fowler T (2010) A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines. Int J Oncol 37:367-376
41. Lawrie CH, Chi J, Taylor S, Tramonti D, Ballabio E, Palazzo S, Saunders NJ, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS (2009) Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. J Cell Mol Med 13:1248-1260
42. Craig VJ, Cogliatti SB, Rehrauer H, Wündisch T, Müller A (2011) Epigenetic silencing of MicroRNA-203 dysregulates ABL1 expression and drives helicobacter-associated gastric lymphomagenesis. Cancer Res 71:3616-3624
43. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353:1793-1801
44. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, DonoM, Dell'AquilaML, Alder H, Rassenti L, Kipps TJ, Bullrich F, Negrini M, Croce CM (2004) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 101:11755-11760